New product: Zeposia (ozanimod hydrochloride) 0.92 mg hard capsules

Ozanimod hydrochloride, a selective immunosuppressant (sphingosine 1-phosphate receptor modulator), is licensed for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease as defined by clinical or imaging features.

Source:

electronic Medicines compendium